Engineered Xenogeneic Bone Scaffold with IL‐10 Nanodelivery System: Immunomodulation and BMSC Fate Programming for Skull Defect Repair
Advanced Science · 2026
DOI: 10.1002/advs.76971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Weihao Lv und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xijing Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Tissue Scaffolds, Interleukin-10, Skull. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Shaanxi Province, Xijing Hospital Medical Staff Training Boost Special Plan, Xijing Hospital Doctoral Dissertation Research Funding.
Abstract (Originalsprache)
Skull defect reconstruction remains clinically challenging because current artificial implants lack bioactivity and produce radiological artifacts, whereas autologous bone grafts suffer from unpredictable resorption and infection. Here, we developed a multifunctional composite integrating antigen‐extracted xenogeneic scaffold, IL‐10‐loaded mesoporous polydopamine nanoparticles (MPDA@IL‐10), and autologous bone marrow‐derived mesenchymal stem cells (BMSCs). The composite establishes a temporally phased immunoregulatory axis: nanoparticle‐delivered exogenous IL‐10 compresses the early inflammatory window, and BMSCs then secrete endogenous anti‐inflammatory factors that prevent scaffold resorption and maintain a pro‐regenerative milieu. Beyond immunomodulation, IL‐10 acts as a lineage‐determining cue, activating PI3K‐Akt/Wnt signaling to drive BMSC osteogenic commitment and suppress adipogenic drift at the early differentiation stage. In a canine critical‐sized skull defect model, this strategy markedly enhanced radiographic and histological regeneration. By uniting temporal immune modulation with stem cell fate programming, this approach offers a translatable route to skull repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Xijing Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, Shaanxi, China.
- Department of Ophthalmology, Xijing Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, Shaanxi, China.
- Department of Radiology, Xijing Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, Shaanxi, China.
ORCID-Profile: Hongchen Zhang, Hongqing Chen, Xia Li, Zhou Fei
Förderung
- Key Research and Development Program of Shaanxi Province
- Xijing Hospital Medical Staff Training Boost Special Plan
- Xijing Hospital Doctoral Dissertation Research Funding
- 2024 Sanqin Special Support Program for Young Top-notch Talents
Zitieren
APA
Lv, W., Zhang, L., Fei, F., Wu, Z., Wu, X., Dou, Y. N., Fu, Y., Chang, H., Qiang, Y., Xie, H., An, N., Chen, L., Zhang, H., Zheng, M. W., Chen, H., Li, X., & Fei, Z. (2026). Engineered Xenogeneic Bone Scaffold with IL‐10 Nanodelivery System: Immunomodulation and BMSC Fate Programming for Skull Defect Repair. Advanced Science. https://doi.org/10.1002/advs.76971
Vancouver
Lv W, Zhang L, Fei F, Wu Z, Wu X, Dou YN, et al. Engineered Xenogeneic Bone Scaffold with IL‐10 Nanodelivery System: Immunomodulation and BMSC Fate Programming for Skull Defect Repair. Advanced Science. 2026. doi:10.1002/advs.76971
BibTeX
@article{Lv2026,
author = {Lv, Weihao and Zhang, Lei and Fei, Fei and Wu, Zhibin and Wu, Xiuquan and Dou, Ya-Nan and Fu, Yihao and Chang, Hao and Qiang, Yujie and Xie, Huaxia and An, Ni and Chen, Leiying and Zhang, Hongchen and Zheng, Min-Wen and Chen, Hongqing and Li, Xia and Fei, Zhou},
title = {Engineered Xenogeneic Bone Scaffold with IL‐10 Nanodelivery System: Immunomodulation and BMSC Fate Programming for Skull Defect Repair},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76971}
}
EUVIMED